Fact sheet: Parvest EqWdHthCre

Fund information
Fund name
Parvest Equity World Health Care Classic Cap EUR
Fund manager company
BNP Paribas Invest Partners Lu
Fund type
Offshore Fund
Fund managers
  • Jon Stephensonsince 02/05/2016
Fund objective
Increase the value of its assets over the medium term.
Benchmark
  • MSCI World [S] Health Care 10/40 (NR)
Investment style
None
Investment method
Shares
Quick stats
1 Year return
15.1%
1 Year rank in sector
14/31
Sector
FO Equity - Pharma Health & Biotech
Yield
-
Ongoing charge (OCF)
?A fund’s ongoing charges figure (OCF) is similar to the old-style total expense ratio. It reflects the annual charge to investors in the fund, in percentage terms, but does not include extra performance-related fees (where these are levied) or the fund’s trading expenses on its underlying investments.
1.98%
Fund size
£337m (£388m last year)
FE Risk score
?FE Risk Scores measure the riskiness of instruments relative to the FTSE 100 index of shares. Weekly volatility is measured over three years with recent behaviour counting more heavily than earlier behaviour. Cash-type investments will have scores close to zero. Funds will tend to have scores in the 0-150 range. The FTSE 100 is always scored at 100. There is no upper limit.
144
Top in this sector
Fund name1 Year
Polar Capital Biotechnology32.4%
Pictet Biotech31.4%
Franklin Biotech Disc25.1%
BB Medtech23.3%
UBS (L)E-Btech$23.2%
...more in FO Equity - Pharma Health & Biotech

Performance snapshot

Holdings snapshot

  • USA68.8%
    Switzerland7.7%
    Ireland7.3%
    UK6.2%
    Germany5.6%
  • Pharmaceuticals44.1%
    Biotechnology/Medical23.6%
    Healthcare & Medical Products17.5%
    Health Care14.8%
  • US Equities68.8%
    UK Equities8.6%
    Swiss Equities7.7%
    Irish Equities7.3%
    German Equities5.6%

Performance vs Sector

Cumulative performance
 1 mth3 mth6 mth1 yr3 yr5 yr
Fund-1.6%4.1%4%15.1%41.8%116.3%
Sector0.6%9.1%1.2%14.1%25.1%105.2%
Rank within sector28 / 3128 / 317 / 3114 / 317 / 2711 / 24
Quartile4th4th1st2nd2nd2nd
Calendar performance
 YTD - 20172016201520142013
Fund5.6%-8.7%15.1%34.9%31.7%
Sector9.3%-9.9%7.2%28.1%41%
Rank within sector28 / 3114 / 315 / 2911 / 2619 / 24
Quartile4th2nd1st2nd4th
Risk statistics
Alpha
?Alpha is a measure of a fund's over- or under-performance by comparison to its benchmark. If the Alpha is 5, the fund has outperformed its benchmark by 5%; so the greater the Alpha, the greater the outperformance.
5
Beta
?Beta estimates a fund's volatility by comparison to that of its benchmark. A fund with a beta close to 1 means that the fund will move generally in line with the benchmark. Higher than 1 and the fund is more volatile than the benchmark and vice versa.
1.01
Sharpe
?This commonly-used measure calculates the level of return over and above the return of a notional risk-free investment, such as cash. The difference in returns is then divided by the fund's volatility. The resulting ratio is an indication of the amount of excess return generated per unit of risk.
0.46
Volatility
?Volatility (or standard deviation), when applied to an investment fund, expresses its risk. It shows how widely a range of returns varied from the fund's average return over a particular period. For example, if a fund had an average return of 5%, and its volatility was 15, this would mean that the range of its returns over the period had swung between +20% and -10%.
17.9
Tracking error
?This measures the standard deviation of a fund's excess returns over the returns of an index or benchmark portfolio. As such, it can be an indication of 'riskiness' in the manager's investment style. A Tracking Error below 2 suggests a passive approach. At 3 and above the the manager will be deploying a more active investment style.
7.14
Information ratio
?This is a useful risk-adjusted measure of actively managed fund performance. It is calculated by deducting the returns of the fund's benchmark from the fund's overall returns, then dividing the result by its tracking error. The higher the Information Ratio the better. It is generally considered that a figure of 0.5 reflects a good performance, 0.75 very good, and 1.00 outstanding.
0.67
R-Squared
?An indication of how closely correlated a fund is to an index or a benchmark. Values for R-Squared range between 0 and 1, with 0 indicating no correlation at all and 1 showing a perfect match. Values upwards of 0.7 suggest that the fund's behaviour is increasingly linked to its benchmark.
0.84
Price movement
52 week high979.09
52 week low804.23
Current bid price-
Current offer price-
Current mid price942.15
Region
1USA68.78%
2Switzerland7.65%
3Ireland7.27%
4UK6.15%
5Germany5.55%
6Jersey2.49%
7Japan2.11%
Industry sector
1Pharmaceuticals44.14%
2Biotechnology/Medical23.62%
3Healthcare & Medical Products17.47%
4Health Care14.77%
Asset type
1US Equities68.78%
2UK Equities8.64%
3Swiss Equities7.65%
4Irish Equities7.27%
5German Equities5.55%
6Japanese Equities2.11%
Individual holdings
1UNITEDHEALTH GROUP INC6.47%
2MERCK & CO INC(NEW)6.04%
3CELGENE CORP5.97%
4ALLERGAN PLC5.84%
5LILLY (ELI) & CO5.06%
6JOHNSON & JOHNSON4.29%
7BOSTON SCIENTIFIC CORP3.93%
8NOVARTIS AG3.67%
9CARDINAL HEALTH INC3.54%
Management
Fund manager group
BNP Paribas Invest Partners
Fund manager company
BNP Paribas Invest Partners Lu
Fund type
Offshore Fund
Fund objective
Increase the value of its assets over the medium term.
Benchmark
  • MSCI World [S] Health Care 10/40 (NR)
Investment style
None
Investment method
Shares
Fund managers
NameSinceBiography
Jon Stephenson02/05/2016
Compliance
Transparent for Austrian Tax, Transparent for Swiss Tax, Transparent for German Tax, Reporting Fund Status, UCITS IV Compliant, UCITS V Compliant, MAS Unrestricted Scheme
Domicile
No data available.
Fund for sale in
Austria, Belgium, Switzerland, Chile, Czech Republic, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Hong Kong, Hungary, Ireland, Italy, Republic Of Korea, Luxembourg, Macau, Netherlands, Norway, Offshore, Portugal, Singapore, Slovakia, Sweden, Taiwan - Province Of China
Parvest Equity World Health Care Classic Cap EUR
Initial charge3%
Annual charge1.5%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.98%
Total expense ratio (TER)1.79%
Bid price-
Offer price-
Mid price942.15
CurrencyEUR
Price updated22/03/2017
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeFN76
Parvest Equity World Health Care Classic Cap SEK
Initial charge3%
Annual charge1.5%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.98%
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price8955.37
CurrencySEK
Price updated22/03/2017
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeETY6
Parvest Equity World Health Care Classic Dis EUR
Initial charge3%
Annual charge1.5%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.97%
Total expense ratio (TER)1.79%
Bid price-
Offer price-
Mid price677.92
CurrencyEUR
Price updated22/03/2017
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeFN77
Parvest Equity World Health Care Classic USD Cap
Initial charge3%
Annual charge1.5%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.97%
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price204.07
CurrencyUSD
Price updated22/03/2017
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeMBS2
Parvest Equity World Health Care Classic USD Cap EUR
Initial charge3%
Annual charge1.5%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.97%
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price182.26
CurrencyEUR
Price updated01/10/2015
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi code00TY
Parvest Equity World Health Care I Cap EUR
Initial charge-
Annual charge0.75%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)0.96%
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price1035.11
CurrencyEUR
Price updated22/03/2017
TypeAccumulation
Institutional or retail classInstitutional
Domicile-
Citi codeDUB1
Parvest Equity World Health Care N Cap EUR
Initial charge-
Annual charge1.5%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)2.72%
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price257.94
CurrencyEUR
Price updated22/03/2017
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeDUB0
Parvest Equity World Health Care Privilege Cap EUR
Initial charge3%
Annual charge0.75%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.22%
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price191.96
CurrencyEUR
Price updated22/03/2017
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeF5SE
Parvest Equity World Health Care Privilege Cap USD
Initial charge3%
Annual charge0.75%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.22%
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price152.61
CurrencyUSD
Price updated14/05/2013
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeF5SF
Parvest Equity World Health Care Privilege Dis EUR
Initial charge3%
Annual charge0.75%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.23%
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price154.15
CurrencyEUR
Price updated22/03/2017
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeFATJ
Parvest Equity World Health Care X Cap EUR
Initial charge-
Annual charge-
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)0.36%
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price184.37
CurrencyEUR
Price updated31/07/2015
TypeAccumulation
Institutional or retail classInstitutional
Domicile-
Citi codeFFTW
Data provided by

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Financial Express. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.